全文获取类型
收费全文 | 9489篇 |
免费 | 404篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 95篇 |
儿科学 | 183篇 |
妇产科学 | 196篇 |
基础医学 | 2170篇 |
口腔科学 | 140篇 |
临床医学 | 604篇 |
内科学 | 1607篇 |
皮肤病学 | 185篇 |
神经病学 | 1104篇 |
特种医学 | 448篇 |
外科学 | 1091篇 |
综合类 | 30篇 |
一般理论 | 1篇 |
预防医学 | 478篇 |
眼科学 | 225篇 |
药学 | 816篇 |
2篇 | |
中国医学 | 9篇 |
肿瘤学 | 538篇 |
出版年
2021年 | 112篇 |
2020年 | 93篇 |
2019年 | 105篇 |
2018年 | 107篇 |
2017年 | 94篇 |
2016年 | 126篇 |
2015年 | 161篇 |
2014年 | 212篇 |
2013年 | 236篇 |
2012年 | 402篇 |
2011年 | 441篇 |
2010年 | 242篇 |
2009年 | 257篇 |
2008年 | 406篇 |
2007年 | 424篇 |
2006年 | 405篇 |
2005年 | 426篇 |
2004年 | 446篇 |
2003年 | 415篇 |
2002年 | 419篇 |
2001年 | 145篇 |
2000年 | 138篇 |
1999年 | 128篇 |
1998年 | 95篇 |
1997年 | 93篇 |
1996年 | 68篇 |
1995年 | 62篇 |
1994年 | 68篇 |
1993年 | 57篇 |
1992年 | 78篇 |
1991年 | 70篇 |
1990年 | 73篇 |
1989年 | 80篇 |
1988年 | 78篇 |
1986年 | 60篇 |
1985年 | 75篇 |
1984年 | 57篇 |
1982年 | 62篇 |
1940年 | 70篇 |
1939年 | 56篇 |
1938年 | 71篇 |
1937年 | 81篇 |
1936年 | 73篇 |
1935年 | 68篇 |
1932年 | 60篇 |
1930年 | 59篇 |
1928年 | 59篇 |
1925年 | 57篇 |
1924年 | 64篇 |
1922年 | 55篇 |
排序方式: 共有9922条查询结果,搜索用时 15 毫秒
991.
Philipp Wohlfarth Roman Ullrich Thomas Staudinger Andja Bojic Oliver Robak Alexander Hermann Barbara Lubsczyk Nina Worel Valentin Fuhrmann Maria Schoder Martin Funovics Werner Rabitsch Paul Knoebl Klaus Laczika Gottfried J Locker Wolfgang R Sperr Peter Schellongowski Arbeitsgruppe für h?mato-onkologische Intensivmedizin der ?sterreichischen Gesellschaft für Internistische und Allgemeine Intensivmedizin und Notfallmedizin 《Critical care (London, England)》2014,18(1)
Introduction
Acute respiratory failure (ARF) is the main reason for intensive care unit (ICU) admissions in patients with hematologic malignancies (HMs). We report the first series of adult patients with ARF and HMs treated with extracorporeal membrane oxygenation (ECMO).Methods
This is a retrospective cohort study of 14 patients with HMs (aggressive non-Hodgkin lymphoma (NHL) n = 5; highly aggressive NHL, that is acute lymphoblastic leukemia or Burkitt lymphoma, n = 5; Hodgkin lymphoma, n = 2; acute myeloid leukemia, n = 1; multiple myeloma, n = 1) receiving ECMO support because of ARF (all data as medians and interquartile ranges; age, 32 years (22 to 51 years); simplified acute physiology score II (SAPS II): 51 (42 to 65)). Etiology of ARF was pneumonia (n = 10), thoracic manifestation of NHL (n = 2), sepsis of nonpulmonary origin (n = 1), and transfusion-related acute lung injury (n = 1). Diagnosis of HM was established during ECMO in four patients, and five first received (immuno-) chemotherapy on ECMO.Results
Before ECMO, the PaO2/FiO2 ratio was 60 (53 to 65), (3.3 to 3.7). Three patients received venoarterial ECMO because of acute circulatory failure in addition to ARF; all other patients received venovenous ECMO. All patients needed vasopressors, and five needed hemofiltration. Thrombocytopenia occurred in all patients (lowest platelet count was 20 (11 to 21) G/L). Five major bleeding events were noted. ECMO duration was 8.5 (4 to 16) days. ICU and hospital survival was 50%. All survivors were alive at follow-up (36 (10 to 58) months); five patients were in complete remission, one in partial remission, and one had relapsed.Conclusions
ECMO therapy is feasible in selected patients with HMs and ARF and can be associated with long-term disease-free survival. 相似文献992.
Neumayer U Schmidt HK Fassbender D Mannebach H Bogunovic N Horstkotte D 《The Journal of heart valve disease》2004,13(5):760-765
BACKGROUND AND AIM OF THE STUDY: Patients with restenosis after open or closed surgical commissurotomy (SC) often demonstrate more severe valve degeneration than patients without prior surgery. This may affect the result of balloon mitral valvotomy (BMV) in this patient group. METHODS: The immediate- and long-term results (maximum 106 months; mean 26 months) of BMV with the Inoue balloon in patients with prior SC were compared with findings in patients without prior surgery. Between February 1989 and July 2001, a total of 1,156 BMV interventions was performed, of which 127 were conducted in patients (106 women, 21 men; mean age 56 +/- 12 years) with prior SC. RESULTS: After BMV, the mitral valve area (MVA) increased from 1.0 +/- 0.2 cm2 to 1.6 +/- 0.4 cm2 after SC compared with 1.0 +/- 0.3 cm2 to 1.8 +/- 0.4 cm2 without SC. After three months, the average MVA was 1.7 +/- 0.3 cm2 in both patient groups. The mean NYHA class improved from 2.8 to 2.0 (after SC) versus 2.7 to 1.8 (no SC) three months after BMV. The main complications were cardiac tamponade in three patients (2.4 %), and more than moderate mitral regurgitation (grade 2+) in six (4.7 %) compared to 5.8% in no-SC patients. CONCLUSION: In view of the satisfactory clinical and hemodynamic results, BMV with the Inoue balloon can be considered the treatment of choice for mitral valve restenosis after SC in selected patients. 相似文献
993.
994.
Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences 下载免费PDF全文
Baraliakos X Hermann KG Landewé R Listing J Golder W Brandt J Rudwaleit M Bollow M Sieper J van der Heijde D Braun J 《Annals of the rheumatic diseases》2005,64(8):1141-1144
OBJECTIVES: To compare the performance of two different MRI sequences-T(1) weighted, fat saturated, spin echo after application of contrast medium, and short tau inversion recovery (STIR) sequences-to detect spinal inflammation in patients with ankylosing spondylitis (AS). METHODS: Both MRI sequences were performed in 38 patients with active AS and compared using the MRI activity scoring system, ASspiMRI-a. One vertebral unit (VU) was defined as the region between two virtual lines drawn through the middle of each vertebral body. RESULTS: Intraclass correlation coefficients were excellent-0.91 and 0.86 for the Gd-DTPA and STIR sequences, respectively. The overall correlation of the single MRI scores for both sequences was also good (r = 0.84, p = 0.01). The intrarater variance was 6.71 and 9.41 and the interrater variance was 13.16 and 19.04 for the Gd-DTPA and STIR sequences, respectively. The smallest detectable distance was 4.7 and 5.6 for the Gd-DTPA and STIR sequences, respectively. The concordance rate for both sequences was 83.5% (range 80.5-87.7% in the three spinal segments). Inflammatory spinal lesions were found in 10.1% of the VUs in the STIR sequence but not in the T(1)/Gd-DTPA sequence, while the T(1)/Gd-DTPA sequence showed inflammatory lesions in 6.4% of the VUs that were found normal by STIR. CONCLUSIONS: Both MRI techniques can evaluate active spinal lesions in patients with AS. More spinal lesions are detected by the STIR sequence, but the reliability between readings and readers is better for the Gd-DTPA sequence. The ASspiMRI-a is a reliable instrument for evaluating acute spinal changes in AS. 相似文献
995.
Heimpel H 《Acta haematologica》2000,103(1):11-15
In severe aplastic anemia, disease-dependent mortality was high before allogeneic bone marrow transplantation (BMT) and immunosuppressive therapies (IST) including antilymphocyte globulin became available. However, under supportive therapy alone, spontaneous remissions were observed in up to 20% of severe cases, reflecting the natural course of the disease. Therefore, in evaluating new forms of treatment, one has to keep in mind that remission is not necessarily response, and that final proof of utility of any new therapy still requires a randomized study design. Transition to leukemia or myelodysplasia was rarely observed if the initial diagnosis was accurate. The much higher incidence of leukemias in patients treated by IST, but not by BMT is probably due to the better life expectancy of patients at risk, rather than to a leukemogenic potential of IST itself. 'Outdated' therapeutic modalities, such as androgens or splenectomy, may still be justified as an adjuvant therapy in selected cases. 相似文献
996.
Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients 总被引:4,自引:0,他引:4
Müller HL Handwerker G Wollny B Faldum A Sörensen N 《The Journal of clinical endocrinology and metabolism》2002,87(8):3993-3996
Craniopharyngioma is a rare dysontogenetic benign tumor. Patients frequently suffer from endocrine deficiencies, sleep disturbances, and obesity due to pituitary and hypothalamic lesions. A self-assessment daytime sleepiness questionnaire (German version of the Epworth Sleepiness Scale) was used to evaluate 79 patients with childhood craniopharyngioma. Because hypothalamic lesions may explain daytime sleepiness in craniopharyngioma patients, salivary melatonin and cortisol concentrations were examined in obese and nonobese craniopharyngioma patients (n = 79), patients with hypothalamic pilocytic astrocytoma (n = 19), and control subjects (n = 30). Using a general linear model procedure analyzing the influence of body mass index (BMI) and tumor diagnosis on diurnal salivary melatonin, we found that morning salivary melatonin levels were related to BMI (by F test, P = 0.004) and tumor diagnosis (by F test, P = 0.032). Also for nighttime salivary melatonin levels significant relations with BMI (by F test, P < 0.001) and tumor diagnosis (by F test, P = 0.025) were detectable. Melatonin concentrations in saliva of craniopharyngioma patients collected at night or in the morning showed a negative correlation (night: Spearman's rho = -0.42; P = 0.001; morning: Spearman's rho = -0.31; P = 0.020) with the patient's Epworth Sleepiness Scale score. Severely obese craniopharyngioma patients and severely obese hypothalamic tumor patients had similar patterns of melatonin secretion. Differences in terms of diurnal salivary cortisol concentrations were not detectable when patient groups and controls were compared. We speculate that hypothalamic lesions might be responsible for both obesity and daytime sleepiness. As decreased nocturnal melatonin levels were associated with increased daytime sleepiness, BMI, and hypothalamic tumor diagnosis, further studies on the beneficial effects of melatonin substitution on daytime sleepiness and weight control in these patients are warranted. 相似文献
997.
998.
Nivison-Smith I Bradstock KF Szer J Durrant S Dodds A Hermann R Schwarer AP Gibson J To LB Arthur C;Australian Bone Marrow Transplant Cooperative Sutdy Group 《Bone marrow transplantation》2001,28(1):21-27
A retrospective comparison was carried out on adult patients receiving HLA-identical allogeneic haemopoietic stem cell transplants from siblings in Australia in 1996, comparing bone marrow with G-CSF-mobilised peripheral blood stem cells. A total of 131 transplant recipients from nine centres were included in this study, of whom 79 received bone marrow, 44 blood stem cells and eight both. All but three of the 131 patients had cyclosporin and methotrexate as graft-versus-host disease prophylaxis. The minimum follow-up time for surviving patients is 27 months. Comparisons were carried out between the BM and PBSC groups. There were no significant differences between groups in age, sex, diagnosis, donor characteristics or pretransplant conditioning. Median time to neutrophil recovery of 0.5 x 10(9)/l was 14 days for PBSC recipients, compared to 19 days for marrow recipients (P < 0.0005). median time to platelet recovery of 20 x 10(9)/l was 17 days for PBSC recipients, compared to 28 days for marrow recipients (P < 0.0005). there were no significantly increased risks of either acute or chronic GVHD in the PBSC recipients. there were no significant differences between the groups in the incidence of major transplant-related complications, disease-free survival or overall survival. 相似文献
999.
1000.